Litigation Note: ProLogic Drops $25M Trade Secrets Lawsuit
Firm News | 1 min read | 06.09.15
Washington, D.C. – June 9, 2015: Aquarian Systems, Inc. (Aquarian) and two of its employees have prevailed in a trade secret lawsuit filed against the company by ProLogic Inc. On June 5, ProLogic voluntarily dismissed—without a settlement—the remaining claims in its $25 million suit, which accused Aquarian and two former ProLogic employees who became employees of Aquarian of trade secret misappropriation, tortious interference, and breach of contract. The claims in the complaint centered around the alleged misappropriation of software created by ProLogic and delivered to the U.S. Department of State (DoS), to which DoS had a broad license. Additionally, ProLogic alleged that the defendants tortiously interfered with ProLogic's business expectancy by submitting a proposal for, and winning, a new DoS contract, which was established as a small business set aside for which ProLogic was ineligible. Crowell & Moring represented Aquarian in this matter, as well as the individual defendants after the claims against Aquarian were dismissed on May 6, 2015.
Insights
Firm News | 5 min read | 08.06.25
Chicago – August 06, 2025: Crowell & Moring today announced that a group of 16 highly regarded health care litigation partners is joining the firm, together with their team, and led by accomplished trial attorney Martin J. Bishop. The strategic combination creates one of the largest health care practices in the country and expands the firm’s ability to provide clients across the industry with the full spectrum of litigation, investigations, regulatory, transactional, and recovery capabilities. The team joins from Reed Smith, where Bishop served on the firm’s executive committee.
Firm News | 1 min read | 07.18.25
OCLBA Honors Tiffany Chang with M. Katherine B. Darmer Outstanding Community Service Award
Firm News | 4 min read | 07.17.25
Crowell & Moring Bolsters California Litigation Group with Two Former Amazon In-House Counsel
Firm News | 1 min read | 07.17.25